From Pilot Project to Partnership: Expanding a Real-World Evidence Platform for Cannabis Research Through China-Brazil Collaboration

Telma Florio; Adriana Marcassa Tucci; Luiza Ramos; Jackeline Barbosa

doi:doi:10.11648/j.hss.20251303.13

Research Article |

| Peer-Reviewed

From Pilot Project to Partnership: Expanding a Real-World Evidence Platform for Cannabis Research Through China-Brazil Collaboration

Telma Florio^*

, Adriana Marcassa Tucci

, Luiza Ramos

, Jackeline Barbosa

Published in Humanities and Social Sciences (Volume 13, Issue 3)

Received: 25 March 2025 Accepted: 4 May 2025 Published: 22 May 2025

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

This article traces the evolution of a real-world evidence (RWE) platform for cannabis research, from its pilot phase as the "Real-World Data on the Therapeutic Response to Cannabis Products in Medical and Veterinary Practice" project in Brazil to its proposed enhancement through a strategic China-Brazil partnership. The initial pilot demonstrated the feasibility of collecting valuable data on therapeutic outcomes, product characteristics, and patient experiences. Building on this foundation, the proposed collaboration leverages China's technological expertise and Brazil's research capacity, specifically Chinese expertise in artificial intelligence (AI), big data analytics, and digital health technology infrastructure, combined with Brazilian capacity in conducting clinical studies, access to diverse patient populations, and knowledge in biodiversity, to scale the platform, incorporate advanced analytics, and harmonize regulatory frameworks, navigating the distinct regulatory landscapes of both countries, including current restrictions in China on cannabinoid use, while acknowledging its role as a major producer of industrial hemp and its growing investment in biotechnological research. This integrated approach aims to accelerate the development of evidence-based cannabis therapies and policies, fostering innovation and responsible growth within the industry, while also addressing planetary health concerns. This approach aims to align scientific advancement with ethical and sustainability considerations, reflecting a planetary health vision.

Published in	Humanities and Social Sciences (Volume 13, Issue 3)
DOI	10.11648/j.hss.20251303.13
Page(s)	219-227
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2025. Published by Science Publishing Group

Keywords

Cannabis, Real-World Evidence, Digital Health, China-Brazil, Real-World Data, Regulatory Harmonization, Planetary Health

References

[1]	[1] International Narcotics Control Board. Report of the International Narcotics Control Board for 2021. United Nations, New York. 2022; 1: 128
[2]	[2] MacCallum, C. A., Russo, E. B. Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine. 2018, 49, 12-19. https://doi.org/10.1016/j.ejim.2018.01.004
[3]	[3] Grand View Research. Legal Marijuana Market Size, Share & Trends Analysis Report By Marijuana Type (Medical, Adult Use), By Product Type (Flower, Oil and Tinctures), By Region, And Segment Forecasts, 2023 - 2030. Published 2023.
[4]	[4] Insights10, “China Medical Marijuana Market Size, Share, Trends, Growth Analysis Report... Industry Forecast 2024-2030.
[5]	[5] Bahji A, Stephenson C, Tyo R, Hawken ER, Crockford D. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of cannabis-based medicines for specific health conditions. BMJ. 2023 Jul 26; 382: e072348. https://doi.org/10.1136/bmj-2022-072348
[6]	[6] Hakami AY, Alshehri FS. Therapeutic potential of cannabinoids in neurological conditions: A systematic review of clinical trials. Front Pharmacol. 2025; 16: 1521792. https://doi.org/10.3389/fphar.2025.1521792
[7]	[7] Gowin JL, Ellingson JM, Karoly HC, et al. Brain function outcomes of recent and lifetime cannabis use. JAMA Netw Open. 2025; 8(1): e2457069. https://doi.org/10.1001/jamanetworkopen.2024.57069
[8]	[8] He J, Baxter SL, Xu J, et al. The practical implementation of artificial intelligence technologies in medicine. Nat Med. 2019; 25: 30–36.
[9]	[9] Volkow ND. A new roadmap for cannabis and cannabis policy research. NIDA Director's Blog. January 25, 2025. Accessed Apr 30, 2025. Available from: https://nida.nih.gov/about-nida/noras-blog/2025/01/new-roadmap-cannabis-cannabis-policy-research
[10]	[10] Krenak A. Ideias para adiar o fim do mundo. São Paulo: Companhia das Letras; 2019.
[11]	[11] Urits I, Gress K, Charipova K, et al. Use of cannabidiol (CBD) for the treatment of chronic pain. Best Pract Res Clin Anaesthesiol. 2020 Sep; 34(3): 463-477. https://doi.org/10.1016/j.bpa.2020.06.004
[12]	[12] Whitmee S, Haines A, Beyrer C, et al. Planetary health: protecting human health on a rapidly changing planet. Lancet. 2015 Nov 28; 386(10009): 2132-3. https://doi.org/10.1016/S0140-6736(15)60901-1
[13]	[13] Silver RJ. The Endocannabinoid System of Animals. Animals (Basel). 2019 Sep 16; 9(9): 686. https://doi.org/10.3390/ani9090686
[14]	[14] Brazilian Health Regulatory Agency (ANVISA). Resolution RDC No. 327, December 9, 2019. Provisions on procedures for the granting of Sanitary Authorization for the manufacture and importation, as well as establishing requirements for the commercialization, prescription, dispensing, monitoring and inspection of Cannabis products for medicinal purposes. Brazilian Official Gazette, December 11, 2019.
[15]	[15] Brazil. U.S. Department of Agriculture, Foreign Agricultural Service (USDA FAS). Brazil’s Initial Hemp Report. GAIN Report Number: BR2023-0036, March 19, 2023.
[16]	[16] Pacher P, Bátkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006 Sep; 58(3): 389-462. https://doi.org/10.1124/pr.58.3.2
[17]	[17] Lu HC, Mackie K. An Introduction to the Endocannabinoid System. Biol Psychiatry. 2016 Apr 1; 79(7): 516-25. https://doi.org/10.1016/j.biopsych.2015.07.028
[18]	[18] Hill MN, Campolongo P, Yehuda R, Patel S. Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder. Neuropsychopharmacology. 2018 Jan; 43(1): 80-102. https://doi.org/10.1038/npp.2017.162
[19]	[19] Rabinak CA, Blanchette A, Zabik NL, et al. Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: a preliminary study. Psychopharmacology (Berl), v. 237, n. 6, p. 1813-1826, jun. 2020. https://doi.org/10.1007/s00213-020-05499-8
[20]	[20] Hanuš LO, Meyer SM, Muñoz E, et al. Phytocannabinoids: a unified critical inventory. Nat Prod Rep. 2016 Nov 23; 33(12): 1357-1392. https://doi.org/10.1039/c6np00074f
[21]	[21] Tudorancea IM, Ciorpac M, Stanciu GD, et al. The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases. Biomedicines. 2022 Oct 6; 10(10): 2492. https://doi.org/10.3390/biomedicines10102492
[22]	[22] Kogan L, Schoenfeld-Tacher R, Hellyer P, Rishniw M. US Veterinarians' Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions. Front Vet Sci. 2019 Jan 10; 5: 338. https://doi.org/10.3389/fvets.2018.00338
[23]	[23] Raup-Konsavage WM. Special Issue: Therapeutic Potential for Cannabis and Cannabinoids. Biomedicines. 2023 Mar 14; 11(3): 902. https://doi.org/10.3390/biomedicines11030902
[24]	[24] Strang CE. Art therapy and neuroscience: evidence, limits, and myths. Front Psychol. 2024 Oct 1; 15: 1484481. https://doi.org/10.3389/fpsyg.2024.1484481
[25]	[25] Casares MA, Díez A, Pérez-Albéniz A, Lucas-Molina B, Fonseca-Pedrero E. Screening for anxiety in adolescents: Validation of the Generalized Anxiety Disorder Assessment-7 in a representative sample of adolescents. J Affect Disord. 2024 Mar; 354(3). https://doi.org/10.1016/j.jad.2024.03.047
[26]	[26] Ribeiro S. O Oráculo da Noite: A História e a Ciência do Sonho. São Paulo: Companhia das Letras; 2019.
[27]	[27] Cash MC, Cunnane K, Fan C, Romero-Sandoval EA. Mapping cannabis-based products: a literature review. Front Pharmacol. 2020 Oct 7; 11: 568458. https://doi.org/10.3389/fphar.2020.568458
[28]	[28] Dariš B, Tancer Verboten M, Knez Ž, Ferk P. Cannabinoids in cancer treatment: Therapeutic potential and legislation. Bosn J Basic Med Sci. 2019 Feb 20; 19(1): 14-23. https://doi.org/10.17305/bjbms.2018.3532
[29]	[29] Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. 2015 Jun 23-30; 313(24): 2456-73. https://doi.org/10.1001/jama.2015.6358
[30]	[30] National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017. https://doi.org/10.17226/24625
[31]	[31] Goodin AJ, Jyot J, Cook RL, et al. Proceedings of the 2024 Cannabis Clinical Outcomes Research Conference. Med Cannabis Cannabinoids. 2024 Oct 23; 7(1): 213-217. https://doi.org/10.1159/000541327
[32]	[32] Di Marzo V, Piscitelli F. The Endocannabinoid System and its Modulation by Phytocannabinoids. Neurotherapeutics. 2015 Oct; 12(4): 692-8. https://doi.org/10.1007/s13311-015-0374-6
[33]	[33] Stuckey HL, Nobel J. The connection between art, healing, and public health: a review of current literature. Am J Public Health. 2010 Feb; 100(2): 254-63. https://doi.org/10.2105/AJPH.2008.156497
[34]	[34] Goodin AJ, Jyot J, Cook RL, Wang Y, Hasan MM, Winterstein AG. Proceedings of the 2024 Cannabis Clinical Outcomes Research Conference. Med Cannabis Cannabinoids. 2024 Oct 23; 7(1): 213-217. https://doi.org/10.1159/000541327
[35]	[35] Portela R, Mota DM, Ferreira PJG, et al. Judicialization of cannabidiol-based products in Brazil: an analysis from 2019 to 2022. Cad Saude Publica. 2023 Oct 9; 39(8): e00024723. https://doi.org/10.1590/0102-311XPT024723
[36]	[36] World Economic Forum. The Future of Jobs Report 2023. May 2023. Accessed Apr 30, 2025. Available from: [Provide specific URL, e.g., https://www.weforum.org/publications/the-future-of-jobs-report-2023/
[37]	[37] UNESCO. Green skills, education and training made their mark at COP 21. Accessed Apr 30, 2025. Available from: Green skills, education and training made their mark at COP 21 \| UNESCO.

Cite This Article

Plain Text BibTeX RIS

APA Style

Florio, T., Tucci, A. M., Ramos, L., Barbosa, J. (2025). From Pilot Project to Partnership: Expanding a Real-World Evidence Platform for Cannabis Research Through China-Brazil Collaboration. Humanities and Social Sciences, 13(3), 219-227. https://doi.org/10.11648/j.hss.20251303.13

Copy | Download

ACS Style

Florio, T.; Tucci, A. M.; Ramos, L.; Barbosa, J. From Pilot Project to Partnership: Expanding a Real-World Evidence Platform for Cannabis Research Through China-Brazil Collaboration. Humanit. Soc. Sci. 2025, 13(3), 219-227. doi: 10.11648/j.hss.20251303.13

Copy | Download

AMA Style

Florio T, Tucci AM, Ramos L, Barbosa J. From Pilot Project to Partnership: Expanding a Real-World Evidence Platform for Cannabis Research Through China-Brazil Collaboration. Humanit Soc Sci. 2025;13(3):219-227. doi: 10.11648/j.hss.20251303.13

Copy | Download

@article{10.11648/j.hss.20251303.13,
  author = {Telma Florio and Adriana Marcassa Tucci and Luiza Ramos and Jackeline Barbosa},
  title = {From Pilot Project to Partnership: Expanding a Real-World Evidence Platform for Cannabis Research Through China-Brazil Collaboration
},
  journal = {Humanities and Social Sciences},
  volume = {13},
  number = {3},
  pages = {219-227},
  doi = {10.11648/j.hss.20251303.13},
  url = {https://doi.org/10.11648/j.hss.20251303.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.hss.20251303.13},
  abstract = {This article traces the evolution of a real-world evidence (RWE) platform for cannabis research, from its pilot phase as the "Real-World Data on the Therapeutic Response to Cannabis Products in Medical and Veterinary Practice" project in Brazil to its proposed enhancement through a strategic China-Brazil partnership. The initial pilot demonstrated the feasibility of collecting valuable data on therapeutic outcomes, product characteristics, and patient experiences. Building on this foundation, the proposed collaboration leverages China's technological expertise and Brazil's research capacity, specifically Chinese expertise in artificial intelligence (AI), big data analytics, and digital health technology infrastructure, combined with Brazilian capacity in conducting clinical studies, access to diverse patient populations, and knowledge in biodiversity, to scale the platform, incorporate advanced analytics, and harmonize regulatory frameworks, navigating the distinct regulatory landscapes of both countries, including current restrictions in China on cannabinoid use, while acknowledging its role as a major producer of industrial hemp and its growing investment in biotechnological research. This integrated approach aims to accelerate the development of evidence-based cannabis therapies and policies, fostering innovation and responsible growth within the industry, while also addressing planetary health concerns. This approach aims to align scientific advancement with ethical and sustainability considerations, reflecting a planetary health vision.
},
 year = {2025}
}

Copy | Download

TY  - JOUR
T1  - From Pilot Project to Partnership: Expanding a Real-World Evidence Platform for Cannabis Research Through China-Brazil Collaboration

AU  - Telma Florio
AU  - Adriana Marcassa Tucci
AU  - Luiza Ramos
AU  - Jackeline Barbosa
Y1  - 2025/05/22
PY  - 2025
N1  - https://doi.org/10.11648/j.hss.20251303.13
DO  - 10.11648/j.hss.20251303.13
T2  - Humanities and Social Sciences
JF  - Humanities and Social Sciences
JO  - Humanities and Social Sciences
SP  - 219
EP  - 227
PB  - Science Publishing Group
SN  - 2330-8184
UR  - https://doi.org/10.11648/j.hss.20251303.13
AB  - This article traces the evolution of a real-world evidence (RWE) platform for cannabis research, from its pilot phase as the "Real-World Data on the Therapeutic Response to Cannabis Products in Medical and Veterinary Practice" project in Brazil to its proposed enhancement through a strategic China-Brazil partnership. The initial pilot demonstrated the feasibility of collecting valuable data on therapeutic outcomes, product characteristics, and patient experiences. Building on this foundation, the proposed collaboration leverages China's technological expertise and Brazil's research capacity, specifically Chinese expertise in artificial intelligence (AI), big data analytics, and digital health technology infrastructure, combined with Brazilian capacity in conducting clinical studies, access to diverse patient populations, and knowledge in biodiversity, to scale the platform, incorporate advanced analytics, and harmonize regulatory frameworks, navigating the distinct regulatory landscapes of both countries, including current restrictions in China on cannabinoid use, while acknowledging its role as a major producer of industrial hemp and its growing investment in biotechnological research. This integrated approach aims to accelerate the development of evidence-based cannabis therapies and policies, fostering innovation and responsible growth within the industry, while also addressing planetary health concerns. This approach aims to align scientific advancement with ethical and sustainability considerations, reflecting a planetary health vision.

VL  - 13
IS  - 3
ER  -

Copy | Download

Author Information

Telma Florio

Department of Pharmacology, Federal University of São Paulo, São Paulo, Brazil

Contact Email

http://orcid.org/0000-0002-7415-8439
Adriana Marcassa Tucci

Department of Biociences, Federal University of São Paulo, Santos, SP, Brazil

Contact Email

http://orcid.org/0000-0002-9180-3452
Luiza Ramos

CANAPSE - National Academic Consortium of Cannabinology, Research and Services, Rio de Janeiro, Brazil

Contact Email

http://orcid.org/0000-0002-8042-8378
Jackeline Barbosa

CANAPSE - National Academic Consortium of Cannabinology, Research and Services, Rio de Janeiro, Brazil

Contact Email

http://orcid.org/0000-0002-4707-2891

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Florio, T., Tucci, A. M., Ramos, L., Barbosa, J. (2025). From Pilot Project to Partnership: Expanding a Real-World Evidence Platform for Cannabis Research Through China-Brazil Collaboration. Humanities and Social Sciences, 13(3), 219-227. https://doi.org/10.11648/j.hss.20251303.13

Copy | Download

ACS Style

Florio, T.; Tucci, A. M.; Ramos, L.; Barbosa, J. From Pilot Project to Partnership: Expanding a Real-World Evidence Platform for Cannabis Research Through China-Brazil Collaboration. Humanit. Soc. Sci. 2025, 13(3), 219-227. doi: 10.11648/j.hss.20251303.13

Copy | Download

AMA Style

Florio T, Tucci AM, Ramos L, Barbosa J. From Pilot Project to Partnership: Expanding a Real-World Evidence Platform for Cannabis Research Through China-Brazil Collaboration. Humanit Soc Sci. 2025;13(3):219-227. doi: 10.11648/j.hss.20251303.13

Copy | Download

@article{10.11648/j.hss.20251303.13,
  author = {Telma Florio and Adriana Marcassa Tucci and Luiza Ramos and Jackeline Barbosa},
  title = {From Pilot Project to Partnership: Expanding a Real-World Evidence Platform for Cannabis Research Through China-Brazil Collaboration
},
  journal = {Humanities and Social Sciences},
  volume = {13},
  number = {3},
  pages = {219-227},
  doi = {10.11648/j.hss.20251303.13},
  url = {https://doi.org/10.11648/j.hss.20251303.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.hss.20251303.13},
  abstract = {This article traces the evolution of a real-world evidence (RWE) platform for cannabis research, from its pilot phase as the "Real-World Data on the Therapeutic Response to Cannabis Products in Medical and Veterinary Practice" project in Brazil to its proposed enhancement through a strategic China-Brazil partnership. The initial pilot demonstrated the feasibility of collecting valuable data on therapeutic outcomes, product characteristics, and patient experiences. Building on this foundation, the proposed collaboration leverages China's technological expertise and Brazil's research capacity, specifically Chinese expertise in artificial intelligence (AI), big data analytics, and digital health technology infrastructure, combined with Brazilian capacity in conducting clinical studies, access to diverse patient populations, and knowledge in biodiversity, to scale the platform, incorporate advanced analytics, and harmonize regulatory frameworks, navigating the distinct regulatory landscapes of both countries, including current restrictions in China on cannabinoid use, while acknowledging its role as a major producer of industrial hemp and its growing investment in biotechnological research. This integrated approach aims to accelerate the development of evidence-based cannabis therapies and policies, fostering innovation and responsible growth within the industry, while also addressing planetary health concerns. This approach aims to align scientific advancement with ethical and sustainability considerations, reflecting a planetary health vision.
},
 year = {2025}
}

Copy | Download

TY  - JOUR
T1  - From Pilot Project to Partnership: Expanding a Real-World Evidence Platform for Cannabis Research Through China-Brazil Collaboration

AU  - Telma Florio
AU  - Adriana Marcassa Tucci
AU  - Luiza Ramos
AU  - Jackeline Barbosa
Y1  - 2025/05/22
PY  - 2025
N1  - https://doi.org/10.11648/j.hss.20251303.13
DO  - 10.11648/j.hss.20251303.13
T2  - Humanities and Social Sciences
JF  - Humanities and Social Sciences
JO  - Humanities and Social Sciences
SP  - 219
EP  - 227
PB  - Science Publishing Group
SN  - 2330-8184
UR  - https://doi.org/10.11648/j.hss.20251303.13
AB  - This article traces the evolution of a real-world evidence (RWE) platform for cannabis research, from its pilot phase as the "Real-World Data on the Therapeutic Response to Cannabis Products in Medical and Veterinary Practice" project in Brazil to its proposed enhancement through a strategic China-Brazil partnership. The initial pilot demonstrated the feasibility of collecting valuable data on therapeutic outcomes, product characteristics, and patient experiences. Building on this foundation, the proposed collaboration leverages China's technological expertise and Brazil's research capacity, specifically Chinese expertise in artificial intelligence (AI), big data analytics, and digital health technology infrastructure, combined with Brazilian capacity in conducting clinical studies, access to diverse patient populations, and knowledge in biodiversity, to scale the platform, incorporate advanced analytics, and harmonize regulatory frameworks, navigating the distinct regulatory landscapes of both countries, including current restrictions in China on cannabinoid use, while acknowledging its role as a major producer of industrial hemp and its growing investment in biotechnological research. This integrated approach aims to accelerate the development of evidence-based cannabis therapies and policies, fostering innovation and responsible growth within the industry, while also addressing planetary health concerns. This approach aims to align scientific advancement with ethical and sustainability considerations, reflecting a planetary health vision.

VL  - 13
IS  - 3
ER  -

Copy | Download